NR1H4 and colitis: Recombinant fibrinogen-like protein 2 improved DSS-induced colitis by reversing the decline in gut microbiota diversity and restoring BA homeostasis by decreasing total BA, increasing FXR and FGF15, and downregulating CYP7A1 [223].